Molecular mechanism of the relation of monoamine oxidase B and its inhibitors to Parkinson's disease: possible implications of glial cells
about
The role of oxidative stress in Parkinson's diseaseDysregulation of glutathione homeostasis in neurodegenerative diseasesCatecholamine autotoxicity. Implications for pharmacology and therapeutics of Parkinson disease and related disordersAdjuvant potential of selegiline in attenuating organ dysfunction in septic rats with peritonitisLipopolysaccharide-induced epithelial monoamine oxidase mediates alveolar bone loss in a rat chronic wound modelNew Therapeutics to Modulate Mitochondrial Function in Neurodegenerative Disorders.Exercise does not protect against MPTP-induced neurotoxicity in BDNF haploinsufficient mice.Medical management of Parkinson's disease: focus on neuroprotectionCatecholamines and Neurodegeneration in Parkinson's Disease-From Diagnostic Marker to Aggregations of α-Synuclein.In Vitro and in Vivo Neuroprotective Effects of Walnut (Juglandis Semen) in Models of Parkinson's DiseaseTrans-differentiation of the adipose tissue-derived stem cells into neuron-like cells expressing neurotrophins by selegilineConcepts of scientific integrative medicine applied to the physiology and pathophysiology of catecholamine systems.The Neuroprotective Effect of Antidepressant Drug via Inhibition of TIEG2-MAO B Mediated Cell Death.Effects of hydrogen sulfide-releasing L-DOPA derivatives on glial activation: potential for treating Parkinson disease.Differential Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on Motor Behavior and Dopamine Levels at Brain Regions in Three Different Mouse Strains.Radio Electric Asymmetric Conveyer Technology Modulates Neuroinflammation in a Mouse Model of Neurodegeneration.Neuroprotective effects of selegiline on rat neural stem cells treated with hydrogen peroxide.The antioxidant and neurochemical activity of Apium graveolens L. and its ameliorative effect on MPTP-induced Parkinson-like symptoms in mice.
P2860
Q24307946-DF01B5D8-A9AB-4BDC-A02A-7374732C9ACCQ26822726-F069539E-391D-477D-85DA-2125F1E0E78EQ26826093-818E0E8C-39E6-4242-9FF9-28B5491FDBEFQ28543423-57685998-D5BB-49A6-BB96-AB32AF58C8EEQ28578321-E8AB3E8B-4AFF-4957-9391-12EC0F5DE728Q33783000-E984CD31-4069-447D-825E-33A97B28A5ABQ34389461-17E7D8DC-7B30-4774-ADD8-4C645D120B36Q35092165-C2ED6F67-7F38-40A7-B751-5F5C2E2B0ACCQ36335146-094D6DF2-500F-481B-BE88-9CFA1CD94B64Q36512635-06C14DC4-6610-40B6-AE79-EE89F4152137Q36734262-1EA21D4F-26E5-4D60-8486-B48F9565AC6EQ36992085-284844F7-C327-4A32-BF11-FCFEF0DC8DEBQ37436980-E2ABD7C8-E708-47E1-9F26-173DC1B5D859Q39718802-358C6916-FA70-4F5E-9420-7D1AB84E8280Q43242399-D1AF69E2-1E48-4A38-BA39-FBFEEC22DCA6Q47613121-61D113D2-5F0E-43A5-A260-3038D3278A2EQ49333997-1A6169E5-EAF8-49BA-AC8D-AE15ACB8FE10Q52646464-4A22121E-93B1-497D-B2D0-E56D8804E19E
P2860
Molecular mechanism of the relation of monoamine oxidase B and its inhibitors to Parkinson's disease: possible implications of glial cells
description
2006 nî lūn-bûn
@nan
2006 թուականին հրատարակուած գիտական յօդուած
@hyw
2006 թվականին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Molecular mechanism of the rel ...... le implications of glial cells
@ast
Molecular mechanism of the rel ...... le implications of glial cells
@en
Molecular mechanism of the rel ...... le implications of glial cells
@nl
type
label
Molecular mechanism of the rel ...... le implications of glial cells
@ast
Molecular mechanism of the rel ...... le implications of glial cells
@en
Molecular mechanism of the rel ...... le implications of glial cells
@nl
prefLabel
Molecular mechanism of the rel ...... le implications of glial cells
@ast
Molecular mechanism of the rel ...... le implications of glial cells
@en
Molecular mechanism of the rel ...... le implications of glial cells
@nl
P1476
Molecular mechanism of the rel ...... le implications of glial cells
@en
P2093
P407
P577
2006-01-01T00:00:00Z